Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001104659-23-008286
Filing Date
2023-01-31
Accepted
2023-01-31 08:57:04
Documents
1
Group Members
ATLAS VENTURE ASSOCIATES IX, L.P.ATLAS VENTURE ASSOCIATES IX, LLC

Document Format Files

Seq Description Document Type Size
1 SC 13G/A tm234424d1_sc13ga.htm SC 13G/A 86794
  Complete submission text file 0001104659-23-008286.txt   88375
Mailing Address 56 WAREHAM STREET, FLOOR 3 BOSTON MA 02118
Business Address 56 WAREHAM STREET, FLOOR 3 BOSTON MA 02118 617-588-2694
Atlas Venture Fund IX, L.P. (Filed by) CIK: 0001671219 (see all company filings)

EIN.: 461357890 | State of Incorp.: DE | Fiscal Year End: 1012
Type: SC 13G/A

Mailing Address 50 HAMPSHIRE STREET, 8TH FLOOR CAMBRIDGE MA 02139
Business Address 50 HAMPSHIRE STREET, 8TH FLOOR CAMBRIDGE MA 02139 617-714-4096
Surface Oncology, Inc. (Subject) CIK: 0001718108 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-90445 | Film No.: 23570368
SIC: 2836 Biological Products, (No Diagnostic Substances)